Yeolyan Launches Brand New Website!
Yeolyan Hematology and Oncology Center, MOH of Armenia shared a proud post on LinkedIn:
”We combine experience and technology for you
We are pleased to inform that the new, rebranded, trilingual website of the Yeolyan Hematology and Oncology Center of the Ministry of Health of the Republic of Armenia is already available.
It was created taking into account modern requirements and standards.
In addition to information about the center’s services, activities, and specialists, you can find useful information and tips for maintaining your health.
We attach great importance to the patient-doctor connection, so through this platform you will have the opportunity to contact a specialist directly and register online for a visit (this opportunity will be fully available in the future).
Particular importance has also been given to blood donors: to reduce the waiting time for donors, as well as to avoid queues on site, a section for donor registration and preliminary completion of the questionnaire has been created.
Everything for your comfort and health. Yeolyan Center for Hematology and Oncology.”
Yeolyan Hematology and Oncology Center is a national centralized hospital for blood disorders, with extensively developed oncology units.
The hospital recently rebranded several of its divisions, including the Hemophilia Center, Transplantation Unit, Blood Bank, Adult Hematology and Oncology Centers, Pediatric Cancer and Blood Disorders Center (PCBDCA) and Palliative Care Center.
The center is also actively engaged in scientific research and clinical trials.
Find all the information on the newly launched official website.
Stay updated with Hemostasis Today.
-
Oct 13, 2025, 03:53Ganesh Mohan is Organising a Webinar to Improve Awareness About Thrombophilia on World Thrombosis Day
-
Oct 13, 2025, 02:47Thomas Reiser: Don't Miss This ISTH Research Recap with Robert Sidonio, Cedric Hermans and Michael Makris
-
Oct 12, 2025, 15:39Renjith Vijayakumar Selvarani: A Heart Attack Isn’t Just a Health Scare — It’s a Medical Emergency
-
Oct 12, 2025, 11:28Is it time for GLP1 receptor agonists in VTE care?
-
Oct 12, 2025, 11:26WFH: Women and Girls with Bleeding Disorders
-
Oct 13, 2025, 03:32Wolfgang Miesbach: This Study from Children's Hospital of Philadelphia Provides Crucial Insights Into Elevidys
-
Oct 13, 2025, 02:43Lukas Meyer and Colleagues on Reperfusion-dependent Treatment Effects of Thrombectomy in Large Ischemic Infarcts
-
Oct 12, 2025, 10:14Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines
-
Oct 12, 2025, 07:28Roberta Gualtierotti: rFVIIIFc and rFIXFc Ensured Effective Haemostasis and Favourable Safety in Major Orthopaedic Surgery
-
Oct 12, 2025, 01:32Evaluating Drug–Drug Interactions in Cancer Patients Receiving Anticoagulants and Antineoplastics
-
Oct 13, 2025, 02:46Flora Peyvandi: First Proposed Blood Test for Chronic Fatigue Syndrome - What Scientists Think
-
Oct 13, 2025, 02:44Silvio Maresca: Honored to be part of this international research project - ThrombUS+
-
Oct 10, 2025, 12:25Robert Lewis: T Cells Are Wonderful - But They Can't Do Everything
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 13, 2025, 03:44Jorge Monge: It Was An Honor to Take Part in the 3rd EBA Workshop on Rare Blood Provision
-
Oct 13, 2025, 03:15Arun V. J: They Chose Death Over A Blood Transfusion — And Here’s Why I Stopped Judging Them
-
Oct 13, 2025, 03:13Rahaf Ajaj: The Persistent Gender Gap in Nobel Prizes - A Call for Greater Inclusion
-
Oct 13, 2025, 02:50Emmanuel J Favaloro: Again Promoting World Thrombosis Day - October 13
-
Oct 12, 2025, 07:38Antonio Vega With Incredible Team Led by the Great Dr Majluf